Sign inGet started

Eckburg Paul

Insider CIK 1914512 · ANTX Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ANTX AN2 Therapeutics, Inc. A Award deriv2024-03-152024-03-1860,000— $060,000SEC↗
ANTX AN2 Therapeutics, Inc. A Award2024-03-152024-03-1830,000— $051,416SEC↗
ANTX AN2 Therapeutics, Inc. A Award2024-03-152024-03-2930,000— $051,416SEC↗
ANTX AN2 Therapeutics, Inc. A Award deriv2023-02-152023-02-1770,950— $070,950SEC↗
ANTX AN2 Therapeutics, Inc. A Award deriv2022-05-122022-05-1666,000— $066,000SEC↗